Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation by Grubb, Anders et al.
    Correspondence: Anders Grubb, MD, PhD, Department of Clinical Chemistry, University Hospital, SE 221 85 Lund, Sweden. Tel:      46 173964. E-mail: 
anders.grubb@med.lu.se   
  (Received     7     October     2010    ; accepted     2     December     2010    ) 
                                                  ORIGINAL ARTICLE         
  Cystatin C, a marker for successful aging and glomerular ﬁ  ltration 
rate, is not inﬂ  uenced by inﬂ  ammation           
        ANDERS         GRUBB    1    ,             JONAS         BJ  Ö  RK    2    ,             ULF         NYMAN    3    ,             JOANNA         POLLAK    1    ,5  ,          
JOHAN         BENGZON    4    ,             GUSTAV           Ö  STNER    1       &               VERONICA         LINDSTR  Ö  M    1       
    1      Department of Clinical Chemistry, Lund University Hospital, Lund, Sweden,   2    Competence Centre for Clinical Research  ,   
Lund University Hospital  ,  Lund  ,   Sweden  ,      3    Department of Radiology  ,  University of Lund  ,  Lasarettet Trelleborg  ,  Trelleborg ,   
Sweden  ,      4    Department of Neurosurgery  ,   Lund University Hospital  ,  Lund  ,  Sweden, and 5                                                            Department of Laboratory Medicine, 
Nicolaus Copernicus University, Collegium Medicum, Bydgoszcz, Poland
  Abstract 
    Background    .   The plasma level of cystatin C is a better marker than plasma creatinine for successful aging. It has been 
assumed that the advantage of cystatin C is not only due to it being a better marker for glomerular ﬁ  ltration rate (GFR) than 
creatinine, but also because an inﬂ  ammatory state of a patient induces a raised cystatin C level. However, the observations 
of an association between cystatin C level and inﬂ  ammation stem from large cohort studies. The present work concerns the 
cystatin C levels and degree of inﬂ  ammation in longitudinal studies of individual subjects without inﬂ  ammation, who undergo 
elective surgery.   Methods    .   Cystatin C, creatinine, and the inﬂ  ammatory markers CRP, serum amyloid A (SAA), haptoglobin 
and orosomucoid were measured in plasma samples from 35 patients the day before elective surgery and subsequently dur-
ing seven consecutive days.   Results    .   Twenty patients had CRP-levels below 1 mg/L before surgery and low levels of the 
additional inﬂ  ammatory markers. Surgery caused marked inﬂ  ammation with high peak values of CRP and SAA on the sec-
ond day after the operation. The cystatin C level did not change signiﬁ  cantly during the observation period and did not 
correlate signiﬁ  cantly with the level of any of the four inﬂ  ammatory markers. The creatinine level was signiﬁ  cantly reduced 
on the ﬁ  rst postoperative day but reached the preoperative level towards the end of the observation period.   Conclusion    .   The 
inﬂ  ammatory status of a patient does not inﬂ  uence the role of cystatin C as a marker of successful aging, nor of GFR.   
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    Introduction 
  Increased levels of cystatin C have been shown to be 
associated with less successful aging than normal 
levels of cystatin C and cystatin C has been described 
to have a better diagnostic performance than creati-
nine to predict successful aging [1  –  6]. It is known 
that a decrease in GFR is associated with less suc-
cessful aging [7,8] and it has therefore been specu-
lated that the advantage of cystatin C as a marker of 
successful aging is caused by it being a better marker 
for GFR than creatinine [1,2,9]. However, studies of 
large patient cohorts have revealed a statistically sig-
niﬁ   cant correlation between cystatin C level and 
degree of inﬂ  ammation and it has therefore been sug-
gested that cystatin C is a marker not only of GFR 
but also of the degree of inﬂ  ammation, thus explain-
ing its superiority as a marker of successful aging 
[5,10  –  13]. But, although signiﬁ  cant statistical cor-
relations between levels of different components in 
cohort studies suggest, they do not demonstrate, 
causal relationships between the levels of the compo-
nents. The present study was undertaken to verify 
or refute a causal relationship between the levels of 
cystatin C or creatinine and the degree of inﬂ  amma-
tion. It concerns modiﬁ  cation of the inﬂ  ammatory 
status of patients and its inﬂ  uence upon their plasma 
levels of cystatin C and creatinine.     
  Materials and methods   
  Study population 
  Thirty-ﬁ   ve patients scheduled for elective surgery, 
with normal body temperatures and able to provide 
written informed consent, without the need for a 
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proxy respondent, were considered for inclusion in 
the study. The study complied with the Declaration 
of Helsinki as revised in 1983. Tissue trauma during 
surgical procedures varied from minor to medium.     
  Determination of protein and creatinine levels 
  Venous blood samples were collected in EDTA-
containing tubes on the day before surgery (Day 0) and 
daily postoperatively for seven days (Day 1 to 7). 
  Plasma CRP, orosomucoid (alpha-1-acid glyco-
protein) and haptoglobin were determined by immu-
noturbidimetry using a Roche-Hitachi cobas 6000 
analysis platform and with a calibrator based upon 
the international calibrator CRM 470 [14]. Reference 
ranges for orosomucoid: 0.5  –  1.2 g/L, and for hapto-
globin: 0.3  –  2.0 g/L [14]. The median CRP-levels in 
the third and seventh decades of healthy individuals 
in the general adult population have been given as 1 
and 2 mg/L, respectively [15]. Plasma cystatin C was 
measured by an automated particle-enhanced immu-
noturbidimetric assay [16] using the same Roche-
Hitachi cobas 6000 analysis platform and a calibrator 
of isolated non-truncated recombinant human 
cystatin C [16]. Reference range: 20  –  50 years of 
age: 0.70  –  1.21 mg/L and, above 50 years of age: 
0.84  –  1.55 mg/L [17]. Plasma SAA was measured by 
an automated particle-enhanced immunonephelo-
metric assay [18] using a Siemens BN ProSpec anal-
ysis system and reagents from Siemens. The 
SAA-values were calibrated against the 1st interna-
tional standard 1997 serum amyloid A protein lot 
92/680 [19]. Reference range: 0.84  –  11.4 mg/L [18]. 
Plasma creatinine was determined by a creatininase-
based procedure using the same Roche-Hitachi cobas 
6000 analysis platform as described above. The crea-
tinine calibrator was traceable to primary reference 
material with values assigned by isotope dilution 
mass spectrometry [20]. Reference ranges for males 
20  –  70 years of age: 56  –  103   μ  mol/L and for females 
20  –  70 years of age: 42  –  82   μ  mol/L [21].     
  Statistical analysis 
  All statistical procedures were performed using SPSS 
release 15.0.0 (SPSS Inc., Chicago, US). To limit the 
problem of multiple comparisons, the time course of 
the levels of each inﬂ  ammatory marker (CRP, SAA, 
haptoglobin and orosomucoid), as well as of creatinine 
and cystatin C, were evaluated by two distinct statisti-
cal tests only: (i) Differences between preoperative 
levels and the ﬁ  rst (CRP, SAA, creatinine and cystatin 
C) or second (haptoglobin and orosomucoid) postop-
erative day were tested using Wilcoxon signed rank 
test; and (ii) for CRP, SAA, creatinine and cystatin 
C, log-linear trends in the changes in levels on post-
operative day 1 through 7 were tested overall, using 
a linear mixed model with the logarithm of the marker 
day 1 through 7 as dependent variable, day as a ﬁ  xed 
continuous covariate and with no random effect but 
a ﬁ  rst-order autoregressive model for the residuals. 
To assess the correlation between inﬂ  ammatory 
markers and creatinine and cystatin C, the mixed 
models with inﬂ   ammatory markers as dependent 
variables were extended by including the natural 
logarithm of creatinine and cystatin C, respectively, 
as ﬁ  xed covariates. Due to missing data at several 
time points, mixed models were preferred to meth-
ods requiring complete data at all time points. 
  p  -values      0.05 were considered signiﬁ  cant.       
  Results 
  The presence of systemic inﬂ  ammation in 35 patients 
scheduled for elective surgery was investigated by 
analysis of the plasma levels of four commonly used 
markers for inﬂ  ammation: CRP, SAA, haptoglobin 
and orosomucoid. The preoperative CRP levels in 
20 of the patients were below 1 mg/L, which is below 
the median CRP level in the third decade of a general 
adult population [15] indicating absence of systemic 
inﬂ  ammation in these 20 patients, which therefore 
were selected for further study. The preoperative lev-
els of orosomucoid and haptoglobin were below the 
upper reference levels for all or 18, respectively, of 
the 20 patients, supporting the absence of pro-
nounced inﬂ   ammation. However, the preoperative 
level of SAA was slightly above the upper reference 
level for 8 of the 20 patients with a maximal level of 
22.5 mg/L, indicating that a low-degree inﬂ  amma-
tion might have been present in some of the patients. 
The levels of cystatin C, 0.72  –  1.45 mg/L, and crea-
tinine, 49  –  115   μ  mol/L, were below, or just above, the 
upper reference limits. 
  The levels of CRP and SAA increased markedly 
on the ﬁ   rst postoperative day (  p        0.001 and 
  p        0.001, respectively) and reached maximal values 
on the second postoperative day with median levels 
corresponding to 46 and 32 times the preoperative 
levels of CRP and SAA, respectively (Figure 1A). 
Both the SAA and CRP levels decreased after the 
second day but were still above the upper reference 
levels on the seventh postoperative day (Figure 1A). 
The levels of haptoglobin and orosomucoid were 
signiﬁ  cantly increased on the second postoperative 
day and did not decrease signiﬁ   cantly during the 
following ﬁ  ve postoperative days (Figure 1B). 
  In contrast to the levels of the inﬂ  ammatory mark-
ers, the cystatin C level did not change signiﬁ  cantly 
on the ﬁ  rst postoperative day (  p        0.20; preoperative 
median      1.08 mg/L, ﬁ   rst postoperative day 
median      1.00 mg/L), and remained stable during 
day 1  –  7 (  p        0.49). Creatinine decreased from 
81  –  65   μ  mol/L in median on the ﬁ  rst postoperative 
day (  p        0.009), but tended to increase again 
during day 1  –  7 (  p        0.19). The median values and      Cystatin C is unaffected by inﬂ  ammation       147
the corresponding 1  st   and 3  rd   quartiles of the CRP, 
SAA, haptoglobin, orosomucoid, creatinine and cys-
tatin C levels are given in Figure 2A  –  F. 
  The cystatin C level showed no statistically sig-
niﬁ   cant correlation with the levels of any of the 
inﬂ   ammatory markers (SAA:   p        0.10, CRP: 
  p        0.65, Haptoglobin:   p        0.72, Orosomucoid: 
  p        0.58). The creatinine level displayed a signiﬁ  cant 
correlation with the SAA level (  p        0.019), but not 
with the levels of any of the other inﬂ  ammatory 
markers (CRP:   p        0.13, Haptoglobin:   p        0.70, 
Orosomucoid:   p        0.80).     
  Discussion 
  It has been suggested that cystatin C is a better 
marker than creatinine for survival success not only 
because it is a better marker for GFR but also because 
the presence of an inﬂ  ammatory reaction in an indi-
vidual produces a raised cystatin C level [5,10  –  13]. 
This suggestion has been based upon demonstration 
of a statistically signiﬁ  cant correlation between the 
levels of CRP, a marker for inﬂ  ammation, and cysta-
tin C in large cohort studies. However, correlations 
in cohort studies can suggest, but not demonstrate, 
causal relationships between the levels of the compo-
nents. The present investigation comprised testing of 
the inﬂ  ammatory status of 20 patients scheduled for 
elective surgery by studying their plasma levels of 
four inﬂ  ammatory markers   –   CRP, SAA, haptoglobin 
and orosomucoid before surgery and during seven 
consecutive postoperative days. CRP and SAA were 
selected because their plasma levels are known to 
increase rapidly and extensively after initiation of 
an inﬂ  ammatory process and swiftly decrease after 
disappearance of the cause of the inﬂ  ammation. 
Haptoglobin and orosomucoid were selected because 
inﬂ  ammation produces a more sustained increase of 
their plasma levels than those of CRP and SAA. The 
20 patients were selected from a larger cohort of 
patients scheduled for elective surgery, because their 
CRP levels were below 1 mg/L, thus indicating the 
absence of inﬂ  ammation in these 20 patients. The 
levels of cystatin C and creatinine in 19 of the 20 
patients were below the upper reference limits. As 
expected, surgery caused a marked increase in the 
plasma levels of all four markers of inﬂ  ammation. 
In contrast, no change in the cystatin C levels could 
be observed during the seven postoperative days. 
Neither did the level of cystatin C show any signiﬁ  -
cant statistical correlation with the levels of any of 
the four markers of inﬂ  ammation. We believe that 
these data strongly argue against the suggestion that 
systemic inﬂ  ammation causes increased plasma lev-
els of cystatin C. However, if inﬂ  ammatory condi-
tions without alterations in the levels of any of 
the four inﬂ   ammatory markers used in this work 
exist, such conditions might theoretically increase 
the cystatin C level. 
  Although the results of the present study might 
seem to be in conﬂ  ict with the previous observations 
of signiﬁ  cant correlations between the plasma levels 
of CRP and cystatin C in cohort studies [5,10  –  13], 
we do not think this is the case. For the cohort stud-
ies concerned the risk of cardiovascular events and 
death in elderly populations and demonstrated that 
higher levels of both cystatin C and CRP were sig-
niﬁ  cantly correlated with higher incidence of cardio-
vascular events and premature death. This means 
that even without a causal relationship between the 
levels of CRP (  ‘  inﬂ  ammation  ’  ) and cystatin C, a sta-
tistical signiﬁ  cant correlation will be found because 
raised levels of both components indicate increased 
risk of cardiovascular events and premature death. 
  The present study indicates that the advantage of 
cystatin C compared to creatinine as a marker of 
successful aging is not due to the fact that an increased 
level of cystatin C signals the presence of inﬂ  amma-
tion in addition to a decrease in GFR, as previously 
suggested [5,10  –  13]. The advantage might, of course, 
solely be related to the fact that cystatin C is a better 
marker for a decrease in GFR than creatinine, but 
additional causes for its superiority as a marker for 
successful aging might be suggested. For example, 
cystatin C might identify the alteration in the com-
position of the glomerular ﬁ   ltrate with a reduced 
ﬁ  ltration of large molecules, e.g. cystatin C (13 343 
Da), but an unaltered ﬁ  ltration of small molecules, 
    Figure 1.         Changes in plasma levels of (A) CRP, SAA, creatinine and 
cystatin C and of (B) orosomucoid, haptoglobin, creatinine and 
cystatin C during seven consecutive days after elective surgery. Day 
zero denotes the day before surgery. The ordinates represent the 
median level of each analyte in multiples of the preoperative level.   148     A. Grubb et al  .   
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